Open access · OA
via OpenAlex
In Vitro Assessment of Mitochondrial Dysfunction and Cytotoxicity of Nefazodone, Trazodone, and Buspirone
James A. Dykens, Joseph D. Jamieson, Lisa D. Marroquin, Sashi Nadanaciva, Jinghai James Xu, Margaret C. Dunn, Arthur R. Smith, Yvonne Will
Toxicological Sciences · 2008 · ▲ 197 citations
Abstract
Mitochondrial toxicity is increasingly implicated in a host of drug-induced organ toxicities, including hepatotoxicity. Nefazodone was withdrawn from the U.S. market in 2004 due to hepatotoxicity. Accordingly, we evaluated nefazodone, another triazolopyridine trazodone, plus the azaspirodecanedione buspirone, for cytotoxicity and effects on mitochondrial function. In accord with its clinical disposition, nefazodone was the most toxic compound of the three, trazodone had relatively modest effects, whereas buspirone showed the least toxicity. Nefazodone profoundly inhibited mitochondrial respiration in isolated rat liver mitochondria and in intact HepG2 cells where this was accompanied by simultaneous acceleration of glycolysis. Using immunocaptured oxidative phosphorylation (OXPHOS) complexes, we identified Complex 1, and to a lesser amount Complex IV, as the targets of nefazodone toxicity. No inhibition was found for trazodone, and buspirone showed 3.4-fold less inhibition of OXPHOS Complex 1 than nefazodone. In human hepatocytes that express cytochrome P450, isoform 3A4, after 24 h exposure, nefazodone and trazodone collapsed mitochondrial membrane potential, and imposed oxidative stress, as detected via glutathione depletion, leading to cell death. Our results suggest that the mitochondrial impairment imposed by nefazodone is profound and likely contributes to its hepatotoxicity, especially in patients cotreated with other drugs with mitochondrial liabilities.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/toxsci/kfn056
- Canonical
- link ↗
- Fetched
- 2026-09-24 MST
Cite this
APA
Dykens, J.A., Jamieson, J.D., Marroquin, L.D., Nadanaciva, S., Xu, J.J., Dunn, M.C., Smith, A.R., & Will, Y. (2008). In Vitro Assessment of Mitochondrial Dysfunction and Cytotoxicity of Nefazodone, Trazodone, and Buspirone. <em>Toxicological Sciences</em>. https://doi.org/10.1093/toxsci/kfn056
Vancouver
Dykens JA, Jamieson JD, Marroquin LD, Nadanaciva S, Xu JJ, Dunn MC, et al. In Vitro Assessment of Mitochondrial Dysfunction and Cytotoxicity of Nefazodone, Trazodone, and Buspirone. Toxicological Sciences. 2008. doi:10.1093/toxsci/kfn056.
BibTeX
@article{james2008InVitr,
title = {In Vitro Assessment of Mitochondrial Dysfunction and Cytotoxicity of Nefazodone, Trazodone, and Buspirone},
author = {James A. Dykens and Joseph D. Jamieson and Lisa D. Marroquin and Sashi Nadanaciva and Jinghai James Xu and Margaret C. Dunn and Arthur R. Smith and Yvonne Will},
journal = {Toxicological Sciences},
year = {2008},
doi = {10.1093/toxsci/kfn056},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PROTEOMICS - CLINICAL APPLICATIONS 2016
Preprint · OA
Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II‐mediated respiration
Free Radical Biology and Medicine 2010
Citation only
Oxidative stress, mitochondrial bioenergetics, and cardiolipin in aging
Antioxidants 2023
Open access · CC-BY
Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease
Physiology 2026
Citation only
Altered mitochondrial bioenergetics in skeletal muscle of horses with pituitary pars intermedia dysfunction
Journal of Clinical Medicine 2021
Open access · CC-BY
Characterization of Mitochondrial Bioenergetics in Preeclampsia
Neurochemistry International 2011
Citation only